Patients participate in clinical trials for a number of reasons. Not only can patients benefit from the treatment being tested, they are also an important part of moving research forward. Another key benefit is the extra attention a patient receives from a specialist during the clinical trial.
By participating in a clinical trial, patients receive one-on-one attention to some of the best Parkinson’s specialists in the country. This offers patients the ability to learn more about their condition while receiving quality care.
Interested in finding a clinical trial? Clinical trials are available near you for patients who have been diagnosed with Parkinson's within the last three years and have not started medication yet.
Patients must not be taking:
- Mirapex® (pramipexole)
- Azilect® (rasagiline)
- Stalevo (carbidopa, levodopa and entacapone)
- Sinemet (carbidopa and levodopa)
- Symmetrel® (amantadine)
- Requip® (ropinirole)
- Eldepryl® (selegiline)
- Cogentin® (benztropine)
